Pulmatrix (NASDAQ:PULM) Stock Price Crosses Above Fifty Day Moving Average – What’s Next?

Pulmatrix, Inc. (NASDAQ:PULM)’s share price passed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $7.44 and traded as high as $7.80. Pulmatrix shares last traded at $7.50, with a volume of 7,163 shares.

Wall Street Analysts Forecast Growth

Separately, StockNews.com started coverage on shares of Pulmatrix in a research note on Sunday, January 5th. They issued a “hold” rating on the stock.

Pulmatrix Stock Down 2.8 %

The stock has a market capitalization of $27.38 million, a P/E ratio of -2.84 and a beta of 1.66. The firm has a 50-day moving average of $7.44 and a 200 day moving average of $5.13.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Pulmatrix stock. Geode Capital Management LLC raised its stake in shares of Pulmatrix, Inc. (NASDAQ:PULM) by 24.6% in the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm owned 36,871 shares of the biotechnology company’s stock after acquiring an additional 7,290 shares during the quarter. Geode Capital Management LLC owned approximately 1.01% of Pulmatrix worth $257,000 as of its most recent filing with the SEC. 11.84% of the stock is currently owned by institutional investors and hedge funds.

About Pulmatrix

Pulmatrix, Inc, a clinical stage biotechnology company, focused on development of novel inhaled therapeutic products to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company offers iSPERSE, an engineered dry powder delivery platform, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications.